Skip to main content
BioInfra Co.,Ltd. logo

BioInfra Co.,Ltd. — Investor Relations & Filings

Ticker · 199730 ISIN · KR7199730003 KO Professional, scientific and technical activities
Open in API
Filings indexed 88 across all filing types
Latest filing 2023-04-25 M&A Activity
Country KR South Korea
Listing KO 199730

About BioInfra Co.,Ltd.

http://bioinfra.co.kr/?lang=en

BioInfra Co., Ltd. is a biotechnology and healthcare company specializing in innovative solutions for disease prevention and early detection, with a primary focus on oncology. The company's core technology is a proprietary multi-biomarker blood test for the early screening of eight major cancers, including lung, liver, stomach, colorectal, prostate, breast, pancreatic, and ovarian cancer. This in vitro diagnostic tool analyzes a small blood sample to assess cancer risk, aiming to improve patient outcomes through early intervention. Beyond diagnostics, BioInfra also engages in pharmaceutical research and development, offering clinical research services and developing cancer gene treatments.

Recent filings

Filing Released Lang Actions
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a formal regulatory disclosure from Bioinfra regarding the 'Decision to Acquire Shares and Equity Securities of Another Corporation' (타법인주식및출자증권취득결정). This type of filing is a standard corporate announcement in the Korean market (DART system) detailing M&A-related activity, specifically the acquisition of a stake in another company (Cluepi Co., Ltd.). Since it details a specific investment/acquisition transaction, it falls under the M&A Activity category.
2023-04-25 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in share ownership (a decrease due to market sales) by a major shareholder (ON Venture Investment). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2023-04-04 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea used to disclose changes in significant share ownership (crossing thresholds). This document specifically details the change in shareholding by '오엔벤처투자㈜' and its special relationship entity in '㈜바이오인프라'. This falls under the category of Major Shareholding Notification.
2023-04-04 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2022, covering the period from January 1, 2022, to December 31, 2022. It includes detailed company information, management history, capital structure, and business operations. In the context of South Korean financial filings (DART system), this is the equivalent of an Annual Report (10-K). FY 2022
2023-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director/auditor compensation limits, and board composition. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of the audit opinion (which is '적정' or 'unqualified') and key financial data (assets, liabilities, revenue, etc.) for the fiscal year. According to the 'Menu vs Meal' rule, this is an announcement of the audit report submission rather than the full audit report document itself. In the context of Korean regulatory filings (DART), this type of disclosure is categorized as a Report Publication Announcement (RPA). FY 2022
2023-03-20 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.